730 related articles for article (PubMed ID: 33121522)
1. Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature.
Jalowiec KA; Andres M; Taleghani BM; Musa A; Dickenmann M; Angelillo-Scherrer A; Rovó A; Kremer Hovinga JA
J Med Case Rep; 2020 Oct; 14(1):206. PubMed ID: 33121522
[TBL] [Abstract][Full Text] [Related]
2. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
3. [Development of acquired hemophilia A during treatment of multiple myeloma with lenalidomide].
Saburi M; Ohtsuka E; Itani K; Nagamatsu K; Ikebe T; Miyazaki Y; Ogata M; Saburi Y
Rinsho Ketsueki; 2015 May; 56(5):496-500. PubMed ID: 26062672
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
Durie BGM; Hoering A; Abidi MH; Rajkumar SV; Epstein J; Kahanic SP; Thakuri M; Reu F; Reynolds CM; Sexton R; Orlowski RZ; Barlogie B; Dispenzieri A
Lancet; 2017 Feb; 389(10068):519-527. PubMed ID: 28017406
[TBL] [Abstract][Full Text] [Related]
5. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
6. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Kumar SK; Jacobus SJ; Cohen AD; Weiss M; Callander N; Singh AK; Parker TL; Menter A; Yang X; Parsons B; Kumar P; Kapoor P; Rosenberg A; Zonder JA; Faber E; Lonial S; Anderson KC; Richardson PG; Orlowski RZ; Wagner LI; Rajkumar SV
Lancet Oncol; 2020 Oct; 21(10):1317-1330. PubMed ID: 32866432
[TBL] [Abstract][Full Text] [Related]
7. Acquired Hemophilia of Unknown Etiology in an Elderly Man: Case Report.
Stephen SE; Loong JLX; Hoong CK; Lim SM; Botross NP
Am J Case Rep; 2018 Jul; 19():858-863. PubMed ID: 30033442
[TBL] [Abstract][Full Text] [Related]
8. [Acquired hemophilia A associated with bullous pemphigoid and multiple myeloma: a case report].
Sourdeau É; Clauser S; Prud'Homme R; Bardet V; Calmette L
Ann Biol Clin (Paris); 2019 Apr; 77(2):179-183. PubMed ID: 30882350
[TBL] [Abstract][Full Text] [Related]
9. Acquired hemophilia masked by warfarin therapy.
Kantor R; Mayan H; Puritz L; Varon D; Farfel Z
Am J Med Sci; 2000 Mar; 319(3):197-201. PubMed ID: 10746834
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
Salwender H; Bertsch U; Weisel K; Duerig J; Kunz C; Benner A; Blau IW; Raab MS; Hillengass J; Hose D; Huhn S; Hundemer M; Andrulis M; Jauch A; Seidel-Glaetzer A; Lindemann HW; Hensel M; Fronhoffs S; Martens U; Hansen T; Wattad M; Graeven U; Munder M; Fenk R; Haenel M; Scheid C; Goldschmidt H
BMC Cancer; 2019 May; 19(1):504. PubMed ID: 31138244
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of acquired hemophilia with oral immunosuppressive therapy.
Shaffer LG; Phillips MD
Ann Intern Med; 1997 Aug; 127(3):206-9. PubMed ID: 9245226
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of VRD(Bortezomib, Lenalidomide, and Dexamethasone) Consolidation Therapy and Maintenance Therapy with Immunomodulatory Drugs(Thalidomide or Lenalidomide) after Autologous Peripheral Blood Stem Cell Transplantation in the Era of Bortezomib-Containing Induction Therapy-A Single Institution Experience.
Tanimura A; Hirai R; Nakamura M; Takeshita M; Togano T; Sekine R; Hagiwara S; Miwa A
Gan To Kagaku Ryoho; 2020 May; 47(5):789-796. PubMed ID: 32408321
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of acquired hemophilia A in elderly patients].
Hayashi T; Morishita E; Asakura H; Nakao S
Nihon Ronen Igakkai Zasshi; 2010; 47(4):329-33. PubMed ID: 20847491
[TBL] [Abstract][Full Text] [Related]
14. [Bullous pemphigoid and acquired hemophilia].
Soria A; Matichard E; Descamps V; Crickx B
Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):353-6. PubMed ID: 17483755
[TBL] [Abstract][Full Text] [Related]
15. Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy.
Ichikawa S; Kohata K; Okitsu Y; Suzuki M; Nakajima S; Yamada MF; Onishi Y; Yamamoto J; Suzuki S; Ishizawa K; Kameoka J; Harigae H
Int J Hematol; 2009 Jul; 90(1):33-36. PubMed ID: 19484333
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of modified bortezomib-lenalidomide-dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.
Okazuka K; Ishida T; Nashimoto J; Uto Y; Sato K; Miyazaki K; Ogura M; Yoshiki Y; Abe Y; Tsukada N; Suzuki K
Eur J Haematol; 2020 Feb; 104(2):110-115. PubMed ID: 31733155
[TBL] [Abstract][Full Text] [Related]
17. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Gay F; Musto P; Rota-Scalabrini D; Bertamini L; Belotti A; Galli M; Offidani M; Zamagni E; Ledda A; Grasso M; Ballanti S; Spadano A; Cea M; Patriarca F; D'Agostino M; Capra A; Giuliani N; de Fabritiis P; Aquino S; Palmas A; Gamberi B; Zambello R; Petrucci MT; Corradini P; Cavo M; Boccadoro M
Lancet Oncol; 2021 Dec; 22(12):1705-1720. PubMed ID: 34774221
[TBL] [Abstract][Full Text] [Related]
18. [PREGNANCY RELATED ACQUIRED HEMOPHILIA A].
Dally N; Kashlikov M
Harefuah; 2019 Mar; 158(3):184-186. PubMed ID: 30916507
[TBL] [Abstract][Full Text] [Related]
19. Immune tolerance therapy in patients with acquired hemophilia.
von Depka M
Hematology; 2004 Aug; 9(4):245-57. PubMed ID: 15621732
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma.
Ibata S; Sato T; Kuroda H; Nagamachi Y; Iyama S; Fujimi A; Kamihara Y; Konuma Y; Yoshida M; Tatekoshi A; Hashimoto A; Horiguchi H; Ono K; Murase K; Takada K; Miyanishi K; Kobune M; Hirayama Y; Kato J
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1041-1049. PubMed ID: 27738809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
